Clinical Trial Update: Trial for Antidepressant Treatment for Negative Symptom of Schizophrenia With NRG1 Risk Genotype [Phase 4]

View source ↗

Summary

An update on a Phase 4 clinical trial evaluating an antidepressant treatment for the negative symptoms of schizophrenia in patients with an NRG1 risk genotype.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Schizophrenia | Phase 4 | Status: UNKNOWN